Algert Global’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Algert Global's EW Position: Q2 2026 in Review
Algert Global sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 44,716 shares — an estimated $3.58M sold.
Algert Global first reported a position in EW in Q3 2021 and held it in 17 quarters. The position peaked at $4.47M in Q4 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Algert Global reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
- Algert Global sold 44,716 Edwards Lifesciences shares in Q2 2026, an estimated $3.58M.
- Algert Global first reported a position in Edwards Lifesciences in Q3 2021 and held it in 17 quarters.
- Algert Global's Edwards Lifesciences position peaked at $4.47M in Q4 2025.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.